SavedAdd your journal

Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2026 / Volume: 73 Issue: 3

Impact of culture medium on antifungal susceptibility results for Microsporum canis and Nannizzia gypsea: A comparative study of disc diffusion and E-test performance

Aziz Utku Önel(Kırıkkale University, Faculty of Veterinary Medicine, Department of Microbiology, Kırıkkale, Türkiye)0000-0003-4596-7461
Murat Yıldırım(Kırıkkale University, Faculty of Veterinary Medicine, Department of Microbiology, Kırıkkale, Türkiye)0000-0002-9576-2280
Pages
—
Publication Date
2026-07-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study provides crucial data to inform reproducible, evidence-based antifungal therapy and to monitor trends in resistance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The absence of standardized culture media for antifungal susceptibility testing (AFST) of animal dermatophytes leads to considerable challenges in result interpretation and treatment selection.
📊
Key Findings & Data:This study aimed to compare the performance of Mueller-Hinton Agar (MHA) and Dermasel Agar (DA) for AFST of feline dermatophytes using disc diffusion and E-test methodologies.
💡
Conclusion & Impact:This study provides crucial data to inform reproducible, evidence-based antifungal therapy and to monitor trends in resistance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antifungal susceptibility test · cat · Microsporum canis

Abstract

The absence of standardized culture media for antifungal susceptibility testing (AFST) of animal dermatophytes leads to considerable challenges in result interpretation and treatment selection. This study aimed to compare the performance of Mueller-Hinton Agar (MHA) and Dermasel Agar (DA) for AFST of feline dermatophytes using disc diffusion and E-test methodologies. Skin and hair samples were collected from cats exhibiting clinical signs of dermatophytosis, including alopecia, erythema, and pruritus. A total of 28 dermatophyte isolates were identified by conventional techniques, of which 26 were identified as Microsporum (M.) canis, and 2 as Nannizzia (N.) gypsea. Antifungal susceptibility to itraconazole, fluconazole, ketoconazole, clotrimazole, posaconazole, and voriconazole was determined using the disc diffusion method on both media. In addition, the E-test method was used to determine the minimum inhibitory concentrations of these antifungal agents. The performance of the media was evaluated according to ISO 11133 standards. Comparison of susceptibility profiles showed that while both M. canis (n=26) and N. gypsea (n=2) were highly susceptible to posaconazole and voriconazole, their efficacy diverged for other agents: itraconazole was effective against M. canis, whereas N. gypsea was more susceptible to clotrimazole. High productivity rates and consistent colony morphology were observed in MHA. Since MHA is a non-selective and nutritionally balanced medium for the AFST of M. canis and N. gypsea, it is preferred over DA. This study provides crucial data to inform reproducible, evidence-based antifungal therapy and to monitor trends in resistance.

🔖

Cite This Article

Önel, A. U., Yıldırım, M. (2026). Impact of culture medium on antifungal susceptibility results for Microsporum canis and Nannizzia gypsea: A comparative study of disc diffusion and E-test performance. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Volume: 73 Issue: 3. https://doi.org/10.33988/auvfd.1695492

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (53)

  1. Afshari MA, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M (2016): Antifungal susceptibility and virulence factors of clinically isolated dermatophytes in Tehran, Iran. Iran J Microbiol, 8, 36-46.
  2. Agarwal RK, Gupta S, Mittal G, et al (2015): Antifungal susceptibility testing of dermatophytes by agar diffusion method. Int J Curr Microbiol App Sci, 4, 430-436. DOI:10.1016/j.mycmed.2022.101291.
  3. Akhoundi M, Nasrallah J, Marteau A, et al (2022): Effect of household laundering, heat drying, and freezing on the survival of Dermatophyte conidia. J Fungi (Basel), 8, 546. DOI:10.3390/jof8050546.
  4. Aktas AE, Yigit N, Aktas A, et al (2014): Investigation of in vitro activity of five antifungal drugs against Dermatophytes species isolated from clinical samples using the e-test method. Eurasian J Med, 46, 26-31. DOI:10.5152/eajm.2014.05.
  5. Alasgarova N, Omarov AM (2023): Clinical, laboratory features and treatment of spontaneously infected dogs and cats with Microsporum canis, in Baku, Ganja, Shamkır and Goygol, Azerbaıjan, during 2021-2022. ELS, 6, 1194-1204.
  6. Aneke CI, Otranto D, Cafarchia C (2018): Therapy and antifungal susceptibility profile of Microsporum canis. J Fungi (Basel), 4, 107. DOI:10.3390/jof4030107.
  7. Aneke CI, Rhimi W, Pellicoro C, et al (2020): The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results. Mycoses, 63, 711-716. DOI:10.1111/myc.13090.
  8. Barrs VR, Hobi S, Wong A, et al (2024): Invasive fungal infections and oomycoses in cats 2. Antifungal therapy. JFMS, 26. DOI:10.1177/1098612X231220047.
  9. Begum J, Kumar R (2020): Prevalence of dermatophytosis in animals and antifungal susceptibility testing of isolated Trichophyton and Microsporum species. Trop Anim Health Prod, 53, 3. DOI:10.1007/s11250-020-02476-3.
  10. Brun S, Pihet M (2021): Laboratory Diagnosis of Dermatophytosis. 355-374. In: JP Bouchara, P Nenoff, AK Gupta, V Chaturvedi (Ed), Dermatophytes and Dermatophytoses. Springer, Cham, Switzerland. DOI:10.10007/978-3-030-67421-2.
  11. Carrillo-Muñoz AJ, Giusiano G, Cárdenes D, et al (2008): Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. Int J Antimicrob Agents, 31, 540-543. DOI:10.1016/j.ijantimicag.2008.01.023.
  12. Chen SC, Sorrell TC (2007): Antifungal agents. Med J Aust, 187, 404-409. DOI:10.5694/j.1326-5377.2007.tb01313.x.
  13. Chermette R, Ferreiro L, Guillot J (2008): Dermatophytoses in animals. Mycopathologia, 166, 385-405. DOI:10.1007/s11046-008-9102-7.
  14. Diren Sığırcı B, Metiner K, Celik B, et al (2019): Dermatophytes isolated from dogs and cats suspected Dermatophytoses in Istanbul, Turkey within a 15-year-period: An updated report. KVJ, 12, 116-121. DOI:10.30607/kvj.495736.
  15. Dogra S, Shaw D, Rudramurthy SM (2019): Antifungal drug susceptibility testing of dermatophytes: Laboratory findings to clinical implications. Indian Dermatol Online J, 10, 225-233. DOI:10.4103/idoj.IDOJ_146_19.
  16. Esteban A, Abarca ML, Cabañes FJ (2005): Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Med Mycol, 43, 61-66. DOI:10.1080/13693780410001711972.
  17. Fernández-Torres B, Carrillo-Muño A, Ortoneda M, et al (2003): Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med Mycol, 41, 125-130. DOI:10.1080/mmy.41.2.125.130.
  18. Fernández-Torres B, Carrillo-Muñoz A, Inza I, et al (2006): Effect of culture medium on the disk diffusion method for determining antifungal susceptibilities of dermatophytes. Antimicrob Agents Chemother, 50, 2222-2224. DOI:10.1128/aac.01443-05.
  19. Ferrier KRM, Van Elk CE, Bunskoek PE, et al (2017): Dosing and therapeutic drug monitoring of voriconazole in bottlenose dolphins (Tursiops truncatus). Med Mycol, 55, 155-163. DOI:10.1093/mmy/myw062.
  20. Fraga CF, Spanamberg A, Ferreiro L, et al (2017): Dermatophytes in Cats without Dermatopathies in the Metropolitan Area of Florianópolis, Brazil. Acta Sci Vet, 45, 7. DOI:10.22456/1679-9216.79382.
  21. Gautam S, Choudhary NS, Gangil R, et al (2024): Prevalence of feline Dermatophytosis in and around Mhow (Indore), MP. IJVSBT, 20, 153-155. DOI:10.48165/ijvsbt.20.4.33.
  22. Gupta A, Venkataraman M (2022): Antifungal resistance in superficial mycoses. J Dermatolog Treat, 33, 1888-1895. DOI:10.1080/09546634.2021.1942421.
  23. International Organization for Standardization (2014): ISO 11133:2014/Amd1:2018. Microbiology of food, animal feed and water- Preparation, production, storage and performance testing of culture media. 1-99. ISO copyright office, Geneva, Switzerland.
  24. Itoi S, Kano R, Hasegawa A, et al (2012): In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals. J Vet Med Sci, 74, 1067-1069. DOI:10.1292/jvms.12-0057.
  25. Ivaskiene M, Matusevicius AP, Grigonis A, et al (2016): Efficacy of topical therapy with newly developed terbinafine and econazole formulations in the treatment of dermatophytosis in cats. Pol J Vet Sci, 19, 535-543. DOI:10.1515/pjvs-2016-0067.
  26. Kano R, Watanabe M, Tsuchihashi H, et al (2023). Antifungal susceptibility testing for Microsporum canis from cats in Japan. Med Mycol J, 64, 19-22. DOI:10.3314/mmj.22-00014.
  27. Karaca N, Koç AN (2004): In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Diagn Microbiol Infect Dis, 48, 259-264. DOI:10.1016/j.diagmicrobio.2003.10.012.
  28. Katiraee F, Kouchak Kosari Y, Soltani M, et al (2021): Molecular identification and antifungal susceptibility patterns of dermatophytes isolated from companion animals with clinical symptoms of Dermatophytosis. J Vet Res, 65, 175-182. DOI:10.2478/jvetres-2021-0020.
  29. Kaya S (2007): Veteriner Farmakoloji. (In Turkish). 4th ed. Medisan, Ankara, Türkiye.
  30. Khadka S, Sherchand J, Pokhrel B, et al (2017): antifungal susceptibility testing of dermatophytes by agar based disk diffusion assay in tertiary care hospital, Nepal. Microbiol Res J Int, 19, 1-5. DOI:10.9734/mrji/2017/31827.
  31. Kidd S, Halliday C, Alexiou H, et al (2016): Descriptions of Medical Fungi. 3rd ed. Newstyle Printing, The National Library of Australia Cataloguing. Adelaide, Australia.
  32. Koch SN, Torres SM, Plumb DC (2012): Canine and Feline Dermatology Drug Handbook. Wiley-Blackwell, USA.
  33. Kukanich B (2008): A review of selected systemic antifungal drugs for use in dogs and cats. Available at https://www.dvm360.com/view/review-selected-systemic-antifungal-drugs-use-dogs-and-cats. (Accessed April 17, 2024).
  34. Liang T, Chen X, de Hoog GS, et al (2025): Antifungal resistance patterns of Microsporum canis: A 27‐Year MIC Study in Mainland China. Mycoses, 68, e70020. DOI:10.1111/myc.70020.
  35. Lopes R, Garces A, Silva A, et al (2024): Dermatophytosis in companion animals in Portugal: A comprehensive epidemiological retrospective study of 12 years (2012–2023). Microorganisms, 12, 1727. DOI: 10.3390/microorganisms12081727.
  36. Mendes AL, Isabel de Azevedo M, Pimenta da Costa-Val Bicalho A (2024): Dermatophytosis in cats: A comprehensive study on diagnostic methods and their accuracy. Open Vet J, 14, 1072-1075. DOI:10.5455/OVJ.2024.v14.i4.14.
  37. Minnat TR, AL-Ezzy AIA, Maroof SW (2021): In vitro susceptibility of antifungal agents against Dermatophytes species isolated from pet dogs. DJVS, 1, 14-22.
  38. Moraru R, Chermette R, Guillot J (2019): Superficial mycoses in dogs and cats. 27-45. In: Singh K, Srivastava N (Ed), Recent Trends in Human and Animal Mycology, Springer, Singapore. DOI:10.1007/978-981-13-9435-5_2.
  39. Moriello KA (2004): Treatment of dermatophytosis in dogs and cats: review of published studies. Vet Dermatol, 15, 99-107. DOI:10.1111/j.1365-3164.2004.00361.x.
  40. Moriello KA, Coyner K, Paterson S, et al (2017): Diagnosis and treatment of dermatophytosis in dogs and cats.: Clinical consensus guidelines of the world association for veterinary dermatology. Vet Dermatol, 28, 266-e68. DOI:10.1111/vde.12440.
  41. Nair SS, Abhishek SKP, Sanjana S, et al (2023): Antifungal susceptibility testing of dermatophytes isolated from animals by disc diffusion assay. J Pharm Innov, 12, 559-562. DOI:10.4103/idoj.IDOJ_146_19.
  42. Namidi M, Ananthnaraja T, Satyasai B (2021): Antifungal susceptibility testing of Dermatophytes by ABDD and E-Test, a comparative study. Open J Med Microbiol, 11, 129-143. DOI:10.4236/ojmm.2021.113011.
  43. Noli C, Colombo S (2020): Feline Dermatology. Springer Nature, Switzerland. DOI:10.1111/vde.12919.
  44. Nweze EI, Mukherjee PK, Ghannoum MA (2010): Agar-based disk diffusion assay for susceptibility testing of dermatophytes. J Clin Microbiol, 48, 3750-3752. DOI:10.1128/JCM.01357-10.
  45. Pakshir K, Bahaedinie L, Rezaei Z, et al (2009): In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur J Microbiol, 2, 158-163. DOI:10.1016/j.ijid.2008.05.762.
  46. Paryuni AD, Indarjulianto S, Widyarini S (2020): Dermatophytosis in companion animals: A review. Vet World, 13, 1174-1181. DOI: 10.14202/vetworld.2020.1174-1181.
  47. Piérard GE, Arrese JE, Piérard-Franchimont C (2000): Itraconazole. Expert Opin Pharmacother, 1, 287-304. DOI:10.1517/14656566.1.2.287.
  48. Pin D (2021): Non-dermatophyte Dermatoses Mimicking Dermatophytoses in Animals. 115-132. In: JP Bouchara, P Nenoff, AK Gupta, V Chaturvedi (Ed), Dermatophytes and Dermatophytoses. Springer, Cham, Switzerland. DOI:10.10007/978-3-030-67421-2.
  49. Popa I, Gros RV, Bucur I, et al (2023): Microsporum Canis strains sensitivity to antifungal drugs. Available at https://www.rjvs.ro/issues/issues/lucrari-stiintifice-medicina-veterinara-timisoara-scientifical-papers-veterinary-medicine-volumul-lvi-2-2023. (Accessed April 23, 2024).
  50. Samanta I (2015): Veterinary Mycology. Springer, India. DOI:10.1007/978-81-322-2280-4.
  51. Singh J, Zaman M, Gupta AK (2007): Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes. Med Mycol, 45, 595-602. DOI:10.1080/13693780701549364.
  52. Vanden Bossche H, Engelen M, Rochette F (2003): Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. J Vet Pharmacol Ther, 26, 5-29. DOI:10.1046/j.1365-2885.2003.00456.x.
  53. Zhou X, Belmonte R, Tang C, et al (2025): Dermatophytes adaptation to the human host exemplified by Microsporum canis. Mycology, 16, 1357-1372. DOI:10.1080/21501203.2025.2461720.